Balchem Beats on Both Top and Bottom Lines
Balchem (NAS: BCPC) reported earnings on Aug. 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Balchem beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share grew.
Gross margins dropped, operating margins were steady, net margins dropped.
Balchem reported revenue of $79.0 million. The three analysts polled by S&P Capital IQ predicted revenue of $76.0 million on the same basis. GAAP reported sales were 5.8% higher than the prior-year quarter's $74.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.33. The three earnings estimates compiled by S&P Capital IQ predicted $0.31 per share. GAAP EPS of $0.33 for Q2 were 3.1% higher than the prior-year quarter's $0.32 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 28.6%, 50 basis points worse than the prior-year quarter. Operating margin was 18.8%, about the same as the prior-year quarter. Net margin was 12.6%, 20 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $77.4 million. On the bottom line, the average EPS estimate is $0.34.
Next year's average estimate for revenue is $306.0 million. The average EPS estimate is $1.31.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 363 members out of 371 rating the stock outperform, and eight members rating it underperform. Among 88 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 88 give Balchem a green thumbs-up, and none give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Balchem is outperform, with an average price target of $33.00.
- Add Balchem to My Watchlist.
The article Balchem Beats on Both Top and Bottom Lines originally appeared on Fool.com.Seth Jaysonhad no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Balchem. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.